ACC 2023: Late-Breaking Science Video Collection

Published: 06 March 2023

  • Views:

    Views Icon 5722
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Our regular review series View from the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provides a critical analysis of the late-breaking and featured science results and spotlights impactful data. 

 

For a deeper look into the key clinical trial data revealed at ACC 23, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviews the principal investigators in her regular Late-Breaker Discussion Series

 

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research. 

More from this programme

Part 3

View from the Thoraxcenter

In these concise episodes of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their thoughts on the top late-breaking trials that will be presented at ACC 2023. 

About the episode

ACC.23/WCC – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principal investigator, Dr Roberto Diletti (Thoraxcenter, Erasmus Medical Center, NL) to explore the findings of the BIOVASC Trial (NCT03621501). 

The primary objective of the BIOVASC Trial was to investigate whether an immediate complete revascularization is non inferior to a staged complete revascularization strategy.

The trial results presented at ACC.23 showed that in ACS patients with multivessel coronary artery disease, an immediate complete revascularization strategy was non inferior to a staged complete revascularization for the composite primary outcome and was associated with lower rates of myocardial infarction and unplanned ischaemia driven revascularization at one-year follow-up.

Recorded on site at ACC 2023, New Orleans.

Faculty Biographies

Roberto Diletti

Roberto Diletti

Interventional Cardiologist

Dr Roberto Diletti is interventional cardiologist at the Thoraxcenter, Erasmus MC, in Rotterdam. He obtained the degree of PhD based upon his research in percutaneous coronary interventions. Dr Roberto Diletti has significant expertise in complex PCI and live cases. Dr Roberto Diletti has a particular interest in CTO education and in the implementation of new technologies and techniques. He is currently leading the clinical research on acute coronary syndromes and the CTO program at Thoraxcenter, Erasmus MC.

View full profile
Harriette Van Spall

Harriette Van Spall

Associate Professor of Medicine, Director of E-Health and Virtual Care

Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.

She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.

Dr Van Spall is an Editorial Board…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.